Key result
Higher integrative polygenic risk score is linked to ~8% higher recurrent stroke risk.
Why the study?
Although genetic instruments can stratify first stroke risk in the general population, whether they are associated with stroke prognosis was unknown.
Does higher genetic risk of first stroke, quantified by an integrative polygenic risk score (iPRS), increase the risk of recurrent stroke, subsequent coronary heart disease, and death among 28-day survivors of a first incident stroke in Chinese and UK populations?
Cohort (n=461,256)
Yes
Does higher genetic risk of first stroke, quantified by an integrative polygenic risk score (iPRS), increase the risk of recurrent stroke, subsequent coronary heart disease, and death among 28-day survivors of a first incident stroke in Chinese and UK populations?
Genetic risk of first stroke, captured by an integrative polygenic risk score, also predicts recurrent stroke and subsequent coronary heart disease among first-stroke survivors in both Chinese and UK populations, with an ~8% absolute risk difference between the top and bottom genetic risk quartiles over 13 years.
Answers are grounded in this paper and cite their sources.
May refine secondary prevention in high-genetic-risk survivors; extends PRS associations to recurrent stroke and CHD but leaves clinical adoption open.
BACKGROUND AND OBJECTIVES: Stroke is known for its poor prognosis. Although genetic instruments have shown promise in stratifying first stroke risk in the general population, it is unknown whether they are associated with stroke prognosis. Our study aims to explore the role of genetic risk of stroke in the progression from stroke-free to first stroke and then to recurrent stroke, subsequent coronary heart disease (CHD), and death in China and the United Kingdom. METHODS: We used data from 2 prospective population-based cohorts, China Kadoorie Biobank (CKB) and UK Biobank (UKB). Participants who were unrelated and free of stroke and CHD at baseline were included. Genetic risks of stroke were quantified using integrative polygenic risk scores (iPRSs), which incorporated summary statistics from multiple genome-wide association studies for stroke outcomes and its subtypes, and vascular-risk traits. We used a multistate model to analyze the roles of genetic risk in the transitions from baseline to first incident stroke and then to recurrent stroke, subsequent CHD, and death. RESULTS: Our study included 80,908 CKB participants and 380,348 UKB participants, with mean ages (% female) of 54.0 years (58.6%) and 56.1 years (55.4%). During median follow-ups of 11.9 years and 13.4 years in the CKB and UKB, respectively, 13,481 and 5,772 participants had their first stroke, neither experienced a CHD, or died within 28 days. These survivors had 5,707 and 943 recurrent strokes, as well as 1,196 and 418 CHD events, respectively. iPRSs were associated with recurrent stroke and CHD among stroke survivors in both populations. The corresponding hazard ratios (HRs) and 95% CIs per SD of iPRSs were 1.08 (1.05-1.11) and 1.08 (1.02-1.15) in CKB and 1.11 (1.03-1.19) and 1.23 (1.10-1.37) in UKB, respectively. There was no association between iPRSs and mortality risk. When we further divided the first stroke into 4 pathologic subtypes, both populations revealed statistically significant associations between iPRSs and the transitions from first ischemic stroke to recurrent stroke and CHD. DISCUSSION: Our study shows that the genetic risk of first stroke also influences the prognosis of stroke survivors, indicating that PRS has the potential to improve stroke prognosis.
No takes yet. Share an insight, caveat, or question.
Han et al. (2025) conducted a cohort in First incident stroke and prognosis among 28-day stroke survivors (n=461,256). Integrative polygenic risk score (iPRS) for stroke per 1-SD increase vs. Lower genetic risk (per SD decrease or lowest quartile of iPRS) was evaluated on Transition from first incident stroke (28-day survivors) to recurrent stroke in China Kadoorie Biobank (HR 1.08, 95% CI 1.05-1.11). Higher integrative polygenic risk scores increased recurrent stroke and subsequent CHD among first-stroke survivors.
Synapse has enriched 10 related papers. Consider them for comparative context: